BRIEF: Teva wins chemotherapy drug patent ruling: According to IMS sales data, Eloxatin had US sales of approximately $1.3 billion in 2008.
TradingMarkets Jun 21 2009 7:42PM GMT
Source: c.moreover.com

NYSE Euronext invests $200mln in Qatar bourse
NYSE Euronext invests $200mln in Qatar bourse
Source: www.gulfbase.com

Beautiful dresses, beautiful memories, with photo gallery: For brides, dream gowns; for cancer patients, a dream fulfilled
Individual.com Jun 21 2009 5:26PM GMT
Source: c.moreover.com

A new weapon in the war against HIV-AIDS: Combined antiviral and targeted chemotherapy
Genetic Engineering News Jun 21 2009 6:52PM GMT
Source: c.moreover.com

Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young scientists
EurekAlert! Jun 21 2009 4:15PM GMT
Source: c.moreover.com

Buy Kava
You can buy the best Kava around right here at Lucid Alchemy. Our source is the freshest, strait from the islands! We strive to find unique kava not found everywhere online, we have connections right on the islands. Our Kava is ALWAYS fresh, and usually ground from fresh root within a couple weeks from when [...]
Source: lucidalchemy.com

Targeting Tumor Behavior May Lead To New Liver Cancer Drugs
Media Newswire Jun 21 2009 3:16PM GMT
Source: c.moreover.com

Homemade Kava Drink Recipe
What you will need: 1. Kava Root (use only fresh raw kava root) 2. cloth strainers 3. soy lecithin (optional) 4. big bowl or pot 5. blender (optional) 6. warm water (not hot) 7. time Directions 1. Put kava (about 1 table spoon per drink) 2. Put a dash of soy lecithin (milk or veg oil works too, you just want to add a little [...]
Source: lucidalchemy.com

Instant Fire Island Kava Sprite
Our Kava supplier let us sample the Instant Fire Island Kava Powder this month. It was simply the best Kava product we have ever experienced. Or at least for me personally this has to be simply the sweetest tasting kava on the market. Yet, there are no additional sweeteners or ingredients. There is no need [...]
Source: lucidalchemy.com

0 comments